Clinical Trials Browser

INDUSTRY × Melanoma × Interferon-alpha × Clear all

NCT00003715 2015-12-03

Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

Phase 2 Terminated

Melanoma

NCT00911443 2009-07-09

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Phase 2 Completed

488 enrolled 12 charts

Melanoma